Alexis Desieno Sells 8,493 Shares of Cardlytics (NASDAQ:CDLX) Stock

Key Points

• CFO Alexis Desieno of Cardlytics sold 8,493 shares at an average price of $2.27, totaling $19,279.11, which decreased their holdings by 4.17%.
• As of recent trading, Cardlytics stock is valued at $2.37 with a market capitalization of $126.18 million and has seen significant trading volume.
• Analysts have downgraded Cardlytics' price target from $3.00 to $2.00, with the current average rating being "Moderate Buy" and a consensus price target of $2.25.

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO Alexis Desieno sold 8,493 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $2.27, for a total value of $19,279.11. Following the sale, the chief financial officer owned 195,417 shares in the company, valued at approximately $443,596.59. This trade represents a 4.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Cardlytics Price Performance

Cardlytics stock traded up $0.01 during mid-day trading on Thursday, hitting $2.37. 3,685,673 shares of the company were exchanged, compared to its average volume of 13,037,717. The company has a market capitalization of $126.18 million, a P/E ratio of -0.65 and a beta of 1.45. Cardlytics, Inc. has a 12-month low of $0.85 and a 12-month high of $5.24. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.16 and a quick ratio of 1.16. The business's 50 day simple moving average is $1.58 and its two-hundred day simple moving average is $1.73.

Hedge Funds Weigh In On Cardlytics

Hedge funds and other institutional investors have recently bought and sold shares of the business. Millennium Management LLC bought a new position in Cardlytics during the 4th quarter worth $535,000. Lane Generational LLC bought a new position in shares of Cardlytics in the first quarter valued at approximately $1,109,000. Deutsche Bank AG lifted its stake in Cardlytics by 123.8% in the first quarter. Deutsche Bank AG now owns 48,728 shares of the company's stock valued at $89,000 after purchasing an additional 26,958 shares during the last quarter. Two Sigma Investments LP lifted its position in shares of Cardlytics by 12.5% during the fourth quarter. Two Sigma Investments LP now owns 94,901 shares of the company's stock worth $352,000 after acquiring an additional 10,508 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new stake in shares of Cardlytics in the fourth quarter worth $43,000. Institutional investors own 68.10% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Evercore ISI reduced their price target on Cardlytics from $3.00 to $2.00 and set an "in-line" rating for the company in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $2.25.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.